Aidapak Recalls Acarbose Tablets Due to Potential Labeling Errors
Aidapak Services, LLC is recalling Acarbose 25 mg tablets because they may be mislabeled as other prescription drugs. The repacked drugs were distributed in four western states.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. Per the rubric, FDA Class II recalls with potential for significant harm (such as receiving the wrong prescription medication) are categorized as Severe.
Plain-English summary
Aidapak Services, LLC is voluntarily recalling Acarbose, Tablet, 25 mg, NDC 00054014025, due to a labeling error. The recall is classified as FDA Class II, indicating a situation that might temporarily cause or contribute to reversible adverse health consequences.
The specific hazard is a label mixup where the Acarbose tablets may be mislabeled as other prescription medications, including Zinc Gluconate, Tolterodine Tartrate ER, Sildenafil Citrate, or Sevelamer Carbonate. This mislabeling could lead to patients receiving the wrong medication.
The repacked drugs were distributed in Arizona, California, Oregon, and Washington. Affected lots include pedigree codes AD60272_1, W002725, W003673, and W002996, with expiration dates ranging from May 22, 2014, to June 25, 2014. Patients and healthcare providers should check their medication labels and contact their pharmacist or the recalling firm if they have questions about the specific products in their possession.
The recalled product
- Product
- ACARBOSE, Tablet, 25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00054014025.
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Prescription Medication
- Affected units
- 399
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (10)
- ACARBOSE
- Tablet
- 25 mg has the following codes: Pedigree: AD60272_1
- EXP: 5/22/2014
- Pedigree: W002725
- EXP: 6/6/2014
- Pedigree: W003673
- EXP: 6/25/2014
- Pedigree: W002996
- EXP: 6/11/2014.
Distribution
Part of a larger recall action
This product is one of 265 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 265 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02